Multidomain integration in the structure of the HNF-4α nuclear receptor complex

Nature

Volumn 495, Issue 7441, 2013, Pages 394-398

  Chandra, Vikas ^a   Huang, Pengxiang ^a   Potluri, Nalini ^a   Wu, Dalei ^a   Kim, Youngchang ^b   Rastinejad, Fraydoon ^a  

^a BURNHAM INSTITUTE   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HOMODIMER; MODY1 PROTEIN; MONOMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; PROTEIN KINASE C; RETINOID X RECEPTOR ALPHA; SERINE; UNCLASSIFIED DRUG;

CHEMICAL BINDING; CRYSTAL STRUCTURE; CYTOLOGY; DNA; GENE EXPRESSION; LIGAND; LIPID; METABOLISM; MUTATION; PEPTIDE; PROTEIN;

ALLOSTERISM; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DNA BINDING; GENE MUTATION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN METHYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE;

HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; HYPOGLYCEMIA; MODELS, MOLECULAR; MUTATION; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84875363845     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11966     Document Type: Article

References (28)

1. Sladek, F. M., Zhong, W. M., Lai, E. & Darnell, J. E. Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4, 2353-2365 (1990).
2. Mangelsdorf, D. J.& Evans, R. M. The RXR heterodimers and orphan receptors. Cell 83, 841-850 (1995).
3. Bolotin, E. et al. Integrated approach for the identification of human hepatocyte nuclear factor 4a target genes using protein binding microarrays. Hepatology 51, 642-653 (2010).
4. Wallerman, O. et al. Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 37, 7498-7508 (2009).
5. Yoon, J. C. et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131-138 (2001).
6. Fang, B., Mane-Padros, D., Bolotin, E., Jiang, T. & Sladek, F. M. Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Nucleic Acids Res. 40, 5343-5356 (2012).
7. Odom, D. T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378-1381 (2004).
8. Ryffel, G. U. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J. Mol. Endocrinol. 27, 11-29 (2001).
9. Ellard, S.& Colclough, K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) inmaturity-onset diabetes of the young. Hum. Mutat. 27, 854-869 (2006).
10. Kapoor, R. R. et al. Hyperinsulinaemic hypoglycaemia. Arch. Dis. Child. 94, 450-457 (2009).
11. Flanagan, S. E. et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur. J. Endocrinol. 162, 987-992 (2010).
12. Chandra, V. et al. Structure of the intact PPAR-c-RXR-a nuclear receptor complex on DNA. Nature 456, 350-356 (2008).
13. Nielsen, R. et al. Genome-wide profiling of PPARc:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 22, 2953-2967 (2008).
14. Jiang, G., Lee, U. & Sladek, F. M. Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization. Mol. Cell. Biol. 17, 6546-6554 (1997).
15. Wisely, G. B. et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10, 1225-1234 (2002).
16. Dhe-Paganon, S., Duda, K., Iwamoto, M., Chi, Y. I.& Shoelson, S. E. Crystal structure of the HNF4a ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277, 37973-37976 (2002).
17. Yuan, X. et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE 4, e5609 (2009).
18. Weigel, N. L. & Moore, N. L. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol. Endocrinol. 21, 2311-2319 (2007).
19. Barrero, M. J. & Malik, S. Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Mol. Cell 24, 233-243 (2006).
20. Sun, K. et al. Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. Mol. Endocrinol. 21, 1297-1311 (2007).
21. Gineste, R. et al. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Mol. Endocrinol. 22, 2433-2447 (2008).
22. Lu, P. et al. Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4a. J. Biol. Chem. 283, 33685-33697 (2008).
23. Rochel,N. et al.Commonarchitectureof nuclear receptorheterodimersonDNAdirect repeat elements with different spacings. Nature Struct.Mol. Biol. 18, 564-570 (2011).
24. Hall, J. M.,McDonnell, D. P.&Korach, K. S. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16, 469-486 (2002).
25. Meijsing, S. H. et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407-410 (2009).
26. Helsen, C. et al. Evidence for DNA-binding domain-ligand-binding domain communications in the androgen receptor. Mol. Cell. Biol. 32, 3033-3043 (2012).
27. Choi, J. H. et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARc by Cdk5. Nature 466, 451-456 (2010).
28. Choi, J. H. et al. Antidiabetic actions of a non-agonist PPARc ligand blocking Cdk5-mediated phosphorylation. Nature 477, 477-481 (2011).